文献速递系统性红斑狼疮

持续缓解与狼疮低疾病活动状态均与SLE患者器官损伤累积减少相关

Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.
PubMed 文献 · Rheumatology (Oxford) · 2016-11-01

该纵向队列研究纳入183例SLE患者,中位随访5.0年,回顾性判定持续缓解与LLDAS。结果显示持续缓解(OR=0.20,95%CI:0.07,0.53,P=0.001)和≥50%观察次数达LLDAS(OR=0.52,95%CI:0.28,0.99,P=0.046)均与损伤累积风险降低相关。

要点

  • 持续缓解与LLDAS≥50%观察次数均与SLICC损伤指数增加≥1风险降低相关。
  • 损伤累积最强预测因素为≥1次主要 flare、随访期平均泼尼松日剂量及基线肾脏表现。
  • 持续缓解者占32.5%(38/117),LLDAS≥50%观察次数者占64.5%(118/183)。

核心结论

  • 持续缓解和LLDAS均与SLE患者器官损伤累积减少相关,提示二者可作为改善预后的治疗目标。

研究设计与样本

  • 前瞻性纵向队列研究,纳入183例SLE患者,中位随访5.0年,每年回顾性判定缓解与LLDAS。

主要发现

  • 损伤累积的最显著预测因素为发生≥1次主要 flare、随访期平均泼尼松日剂量及基线肾脏表现。
  • 持续缓解存在于32.5%(38/117)患者,LLDAS在≥50%观察次数中存在于64.5%(118/183)患者。
  • 持续缓解与损伤累积风险降低相关(OR=0.20,95%CI:0.07,0.53,P=0.001)。
  • ≥50%观察次数达LLDAS与损伤累积风险降低相关(OR=0.52,95%CI:0.28,0.99,P=0.046)。

关键数值与推荐

  • 损伤累积定义为随访期间SLICC损伤指数增加≥1。
  • 持续缓解为5年随访期间持续处于缓解状态。
  • LLDAS达标定义为≥50%的观察次数达到狼疮低疾病活动状态。

临床怎么用

  • 在SLE长期管理中,可将持续缓解或LLDAS作为治疗目标以降低器官损伤累积风险。
  • 应关注主要 flare 发生、泼尼松累积剂量及基线肾脏受累以识别损伤高风险患者。

局限性

  • 缓解与LLDAS为回顾性判定,非前瞻性实时评估。
  • 原文未报告研究人群的具体人口学特征及治疗方案的详细信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To identify predictors of organ damage and specifically the relationship between prolonged disease remission or low disease activity and damage accrual in a longitudinal cohort of SLE patients. METHODS: Data were prospectively assessed including the occurrence of minor/major flares. Once a year remission and Lupus Low Disease Activity State (LLDAS) were determined retrospectively. A prediction model for damage accrual during follow-up was constructed with backward logistic regression analyses. Secondly, odds ratios (ORs) for damage accrual (SLICC damage index increase of ⩾ 1 during follow-up) were calculated for patients with or without prolonged remission during 5 years, and with or without LLDAS in ⩾ 50% of observations. RESULTS: Data from 183 patients with a median follow-up duration of 5.0 years were analysed. The most significant predictors for damage accrual were: occurrence of ⩾ 1 major flare, mean daily prednisone dose during follow-up and nephrological manifestations at baseline. Prolonged remission was present in 32.5% (38/117) and LLDAS in ⩾ 50% of observations in 64.5% (118/183) of patients. Both the presence of prolonged remission during 5 years and LLDAS in ⩾ 50% of observations were associated with a reduced risk of damage accrual (OR = 0.20, 95% CI: 0.07, 0.53, P = 0.001 and OR = 0.52, 95% CI: 0.28, 0.99, P = 0.046, respectively). CONCLUSION: This cohort study shows that prolonged remission and LLDAS were associated with an improved outcome, as determined by yearly assessments. In order to improve the outcome in SLE patients, future studies should investigate whether these targets can be reached actively with therapeutic strategies.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Tsang-A-Sjoe MW, Bultink IE, Heslinga M, et al. Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus. Rheumatology (Oxford). 2016. PMID: 27803306. doi:10.1093/rheumatology/kew377

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。